Products & Services · Total Revenue

Licensing and royalty revenue — Total Revenue

Year-over-year, this metric declined by 100.0%, from $8.00M to $0.00. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026May 1, 2026
Rolls up toTotal Revenue

How to read this metric

An increase suggests successful commercialization of intellectual property through partners, while a decrease may indicate expiring patents or reduced partner activity.

Detailed definition

This metric represents the total gross revenue recognized from licensing intellectual property and royalty agreements wi...

Peer comparison

Common in biotech and pharmaceutical firms that out-license non-core assets or partner on early-stage clinical programs.

Metric ID: mrna_segment_licensing_and_royalty_revenue_total_revenue

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$30.00M$7.00M$5.00M$8.00M$2.00M$2.00M$0.00$0.00
QoQ Change-76.7%-28.6%+60.0%-75.0%+0.0%-100.0%
YoY Change-93.3%-71.4%-100.0%-100.0%
Range$0.00$30.00M
Avg YoY Growth-91.2%
Median YoY Growth-96.7%
Current Streak2 quarters decline

Frequently Asked Questions

What is Moderna's licensing and royalty revenue — total revenue?
Moderna (MRNA) reported licensing and royalty revenue — total revenue of $0.00 in Q1 2026.
How has Moderna's licensing and royalty revenue — total revenue changed year-over-year?
Moderna's licensing and royalty revenue — total revenue decreased by 100.0% year-over-year, from $8.00M to $0.00.
What does licensing and royalty revenue — total revenue mean?
The total income earned from licensing out technology and receiving royalty payments.